Data Protection Statement

Effective as of 17-May-2018

Flex Databases provides software solutions that support clinical trials conduction at all stages and one of our main priorities is confidentiality and integrity of our customers data. Flex Databases is concerned about data protection and privacy issues. This Statement describes basic principles of the data collection, usage, and disclosure.

This Statement refers to information that Flex Databases receives through this Website (further: site). By providing personal information to us or by using the site, you agree to the terms and conditions of this Data Protection Statement.

Flex Databases collects the following information through this site:

  • Name, job title, contact e-mail address and telephone number provided by you in the corresponding fields
  • Personal data for job application, including CV, if you provide it in the corresponding fields
  • IP Address. Flex Databases may collect IP addresses during this site operation. Collecting IP Addresses is the automatically fulfilled routine practice. We use IP Addresses to calculate usage levels of the site, diagnose problems with the servers, administer the site, and monitor the regions from which you navigate to our site.
  • Cookies. Cookies are pieces of information transferred directly on the computer you are using. Cookies provide information such as browser type, time spent on the site, pages visited, and language preferences. We may use the information for security purposes, to facilitate navigation, display information more effectively.

You can refuse to accept these cookies by adjusting your browser’s settings. In this case you may experience some inconveniences when navigating the site.

Use and Sharing of Your Personal Information

Flex Databases uses the Personal Information we collect from you:

  • to contact you after you have requested demo/sent us an inquiry via our site
  • to send newsletters
  • to send marketing communications
  • as required by law or regulation, or as requested by government authorities
  • in connection with an acquisition, merger, sale or other transfer of all or substantially all our business or portion thereof
  • to respond to questions and concerns
  • to improve our site and marketing efforts
  • to conduct research and analysis
  • to respond to inquiries regarding career opportunities

We will keep your personal information for the time required to fulfill the outlined in this Data Protection Statement purposes unless a longer retention period is required by law.

Flex Databases doesn’t provide your personal data to any third parties unless permitted or required by law without making you aware and/or acquiring your explicit consent.

We implement appropriate organizational and technical measures to protect the personal data in our possession from misuse, unauthorized access and disclosure.

How to contact us about privacy

You have the right to request access to your personal data that we have collected and to request the copy of this data. You can request to correct or erase the personal data that you provided to Flex Databases. You can address your concerns and questions regarding privacy to dl_privacy@flexdatabases.com.

Blog

Testimony Agenus
Why Agenus Chose Flex Databases: A Client’s Perspective

October, 2024 – Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a strong pipeline of immune modulating antibodies, together with Flex Databases announce the successful implementation of Flex Databases’ Clinical Trial Management System (CTMS) and electronic Trial Master File (eTMF) solutions, including a new AI-driven feature for automated document filing and metadata assignment. This partnership […]

Learn more
FDA guidance
FDA Releases Guidance on Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers

In October 2024, the U.S. Food and Drug Administration issued a final guidance titled Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers. https://www.fda.gov/media/166215/download    This guidance provides recommendations on the use of electronic systems, electronic records and electronic signatures in food, medical product, tobacco product, and new animal drug clinical investigations.  […]

Learn more
FGK Interview, Martin Krauss
Client Spotlight: FGK Clinical Research GmbH CRO’s Experience with Flex Database

We had the pleasure of sitting down with Martin Krauss, Co-Founder and Managing Director of FGK CRO, to discuss how Flex Databases has supported their clinical research operations over the past 3.5 years.In this interview, Martin shares: • Why FGK CRO initially chose to partner with Flex Databases.• How our CTMS, TMF, and LMS solutions have transformed […]

Learn more
product updates
Exciting Updates: Enhancements to Our Platform!

We are thrilled to share several key enhancements that will streamline your workflows and improve data management.  Enhanced Duplicates Search Our Duplicates Search feature has received a significant upgrade! The system now identifies 100% duplicate files from your Inbox by checksum, ensuring cleaner data management. When files are moved from the Inbox to any folder […]

Learn more

Get in touch to discuss compliance, implementation, demos, pricing

We are here for all of your questions! Tell us more about yourself and we will organize a tailored live demo to show how you can power up your clinical trials processes with Flex Databases.